Figure 2From: PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversityComparison of ten web-accessible methods for HLA class II peptide-binding prediction. Only peptides displaying high-affinity binding (IC50 ≤ 50 nM) from the DFRMLI dataset were used. Bars indicate the average AUCs.Back to article page